GILEAD SCIENCES, INC.
GILDNasdaqGSLatest results at a glance
Insights from the latest company results and reports · filed 4 Aug 2026
Acquisition-Driven Earnings Loss
GAAP diluted EPS was $(8.45) in the second quarter of 2026, primarily due to a $(9.08) per share impact from acquired in-process research and development expenses.
Stable Product Gross Margins
Product gross margin remained relatively flat at 79.3% in the second quarter of 2026, compared to 78.7% in the same period of 2025.
Cash Depletion from Acquisitions
Cash and marketable securities decreased to $3.2 billion as of June 30, 2026.
Increased 2026 Revenue Expectations
The company increased its base business revenue expectations for 2026, citing 10% year-over-year growth in the base business.
Company research evidence
Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.
Loading evidence…
Deep Dive Research
Source-linked company research for GILD
Revenue segmentation
Loading segment disclosures…